200 related articles for article (PubMed ID: 20371352)
1. PlGF blockade does not inhibit angiogenesis during primary tumor growth.
Bais C; Wu X; Yao J; Yang S; Crawford Y; McCutcheon K; Tan C; Kolumam G; Vernes JM; Eastham-Anderson J; Haughney P; Kowanetz M; Hagenbeek T; Kasman I; Reslan HB; Ross J; Van Bruggen N; Carano RA; Meng YJ; Hongo JA; Stephan JP; Shibuya M; Ferrara N
Cell; 2010 Apr; 141(1):166-77. PubMed ID: 20371352
[TBL] [Abstract][Full Text] [Related]
2. Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy.
Yao J; Wu X; Zhuang G; Kasman IM; Vogt T; Phan V; Shibuya M; Ferrara N; Bais C
Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11590-5. PubMed ID: 21709213
[TBL] [Abstract][Full Text] [Related]
3. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.
Carmeliet P; Moons L; Luttun A; Vincenti V; Compernolle V; De Mol M; Wu Y; Bono F; Devy L; Beck H; Scholz D; Acker T; DiPalma T; Dewerchin M; Noel A; Stalmans I; Barra A; Blacher S; VandenDriessche T; Ponten A; Eriksson U; Plate KH; Foidart JM; Schaper W; Charnock-Jones DS; Hicklin DJ; Herbert JM; Collen D; Persico MG
Nat Med; 2001 May; 7(5):575-83. PubMed ID: 11329059
[TBL] [Abstract][Full Text] [Related]
4. Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice.
Malik AK; Baldwin ME; Peale F; Fuh G; Liang WC; Lowman H; Meng G; Ferrara N; Gerber HP
Blood; 2006 Jan; 107(2):550-7. PubMed ID: 16189273
[TBL] [Abstract][Full Text] [Related]
5. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model.
Brave SR; Eberlein C; Shibuya M; Wedge SR; Barry ST
Angiogenesis; 2010 Dec; 13(4):337-47. PubMed ID: 20953695
[TBL] [Abstract][Full Text] [Related]
6. Anti-placental growth factor reduces bone metastasis by blocking tumor cell engraftment and osteoclast differentiation.
Coenegrachts L; Maes C; Torrekens S; Van Looveren R; Mazzone M; Guise TA; Bouillon R; Stassen JM; Carmeliet P; Carmeliet G
Cancer Res; 2010 Aug; 70(16):6537-47. PubMed ID: 20682798
[TBL] [Abstract][Full Text] [Related]
7. Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels.
Fischer C; Jonckx B; Mazzone M; Zacchigna S; Loges S; Pattarini L; Chorianopoulos E; Liesenborghs L; Koch M; De Mol M; Autiero M; Wyns S; Plaisance S; Moons L; van Rooijen N; Giacca M; Stassen JM; Dewerchin M; Collen D; Carmeliet P
Cell; 2007 Nov; 131(3):463-75. PubMed ID: 17981115
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs.
Hedlund EM; Yang X; Zhang Y; Yang Y; Shibuya M; Zhong W; Sun B; Liu Y; Hosaka K; Cao Y
Proc Natl Acad Sci U S A; 2013 Jan; 110(2):654-9. PubMed ID: 23267058
[TBL] [Abstract][Full Text] [Related]
9. Placental growth factor upregulation is a host response to antiangiogenic therapy.
Bagley RG; Ren Y; Weber W; Yao M; Kurtzberg L; Pinckney J; Bangari D; Nguyen C; Brondyk W; Kaplan J; Teicher BA
Clin Cancer Res; 2011 Mar; 17(5):976-88. PubMed ID: 21343374
[TBL] [Abstract][Full Text] [Related]
10. Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence.
Taylor AP; Rodriguez M; Adams K; Goldenberg DM; Blumenthal RD
Int J Cancer; 2003 Jun; 105(2):158-64. PubMed ID: 12673673
[TBL] [Abstract][Full Text] [Related]
11. Combined Anti-PLGF and Anti-Endostatin Treatments Inhibit Ocular Hemangiomas.
Jiang H; Wu X; Wang H; Huang C; Zhang L
Cell Physiol Biochem; 2015; 36(3):930-6. PubMed ID: 26088746
[TBL] [Abstract][Full Text] [Related]
12. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.
Luttun A; Tjwa M; Moons L; Wu Y; Angelillo-Scherrer A; Liao F; Nagy JA; Hooper A; Priller J; De Klerck B; Compernolle V; Daci E; Bohlen P; Dewerchin M; Herbert JM; Fava R; Matthys P; Carmeliet G; Collen D; Dvorak HF; Hicklin DJ; Carmeliet P
Nat Med; 2002 Aug; 8(8):831-40. PubMed ID: 12091877
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of placenta growth factor with TB-403: a novel antiangiogenic cancer therapy.
Nielsen DL; Sengeløv L
Expert Opin Biol Ther; 2012 Jun; 12(6):795-804. PubMed ID: 22506966
[TBL] [Abstract][Full Text] [Related]
14. Tumor angiogenesis and anti-angiogenic therapies.
Shahneh FZ; Baradaran B; Zamani F; Aghebati-Maleki L
Hum Antibodies; 2013; 22(1-2):15-9. PubMed ID: 24284305
[TBL] [Abstract][Full Text] [Related]
15. Human choriocarcinomas: placental growth factor-dependent preclinical tumor models.
Bagley RG; Ren Y; Kurtzberg L; Weber W; Bangari D; Brondyk W; Teicher BA
Int J Oncol; 2012 Feb; 40(2):479-86. PubMed ID: 22075622
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth.
Laakkonen P; Waltari M; Holopainen T; Takahashi T; Pytowski B; Steiner P; Hicklin D; Persaud K; Tonra JR; Witte L; Alitalo K
Cancer Res; 2007 Jan; 67(2):593-9. PubMed ID: 17234768
[TBL] [Abstract][Full Text] [Related]
17. Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation.
Yoo SA; Yoon HJ; Kim HS; Chae CB; De Falco S; Cho CS; Kim WU
Arthritis Rheum; 2009 Feb; 60(2):345-54. PubMed ID: 19180491
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor-dependent spatiotemporal dual roles of placental growth factor in modulation of angiogenesis and tumor growth.
Yang X; Zhang Y; Yang Y; Lim S; Cao Z; Rak J; Cao Y
Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13932-7. PubMed ID: 23918367
[TBL] [Abstract][Full Text] [Related]
19. Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy.
Taylor AP; Osorio L; Craig R; Raleigh JA; Ying Z; Goldenberg DM; Blumenthal RD
Clin Cancer Res; 2002 Apr; 8(4):1213-22. PubMed ID: 11948135
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of placental growth factor in renal cell carcinoma.
Bessho H; Wong B; Huang D; Siew EY; Huang D; Tan J; Ong CK; Tan SY; Matsumoto K; Iwamura M; Teh BT
Anticancer Res; 2015 Jan; 35(1):531-41. PubMed ID: 25550599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
